Clinical Trial Update: Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6 [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating the combination of methotrexate and actinomycin D in low-risk gestational trophoblastic neoplasia with score 5-6.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasia

Drugs mentioned

• Actinomycin D (dactinomycin)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Gestational Trophoblastic Tumor, Effects of Chemotherapy | Phase 2, Phase 3 | Status: UNKNOWN